| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.29 | 0.0006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.003 |